05.07.2013 • NewsRhein Chemieindustrial locationsLanxess

Rhein Chemie Opens First Rubber Additives Plant in Russia

Germany's Rhein Chemie, a subsidiary of specialty chemicals producer Lanxess, has opened its first Russian production facility. The new 1,500 t/y plant at Lipetsk will manufacture the company's pre-dispersed polymer-bound additives for the rubber industry in Russia and the CIS countries. A plant to produce 80,000 bladders for the tire industry is due to be added in 2016.

Lanxess said the investment at Lipetsk, which in the medium term will create 40 jobs at the site, "amounts to a seven-digit euro figure."

The product range, marketed under the "Rhenogran" brand name, includes accelerators, sulfur donors, antioxidants and crosslinking activators used to produce tires and automotive seats as well as technical rubber products such as extruded profiles and hoses.

"Opening our first production facility in Russia marks yet another milestone in our long-term commitment to this market. The new plant will enable us to harness market potential more effectively, particularly in the automotive and tire industries," said Lanxess managing board member Werner Breuers.

Lanxess cites studies estimating medium-term annual growth rates for these industries in the mid-to-high single-digit euro range. Since entering the Russian market in 2009, the company has quadrupled sales and established strategic partnerships in our target markets and with research institutes, Breuers said. (dw)

 

 

 

 

 

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read